Krystian Kozek joined Flagship Pioneering as an Associate after completing the firm's 2021 Flagship Pioneering Fellowship. In his role, Krystian works to identify new opportunities to advance platform technologies into therapeutic applications for Pioneering Medicines.
Krystian received his M.D. from Vanderbilt University, where he also completed his Ph.D. in Pharmacology through the Medical Scientist Training Program (MSTP) working in the laboratory of Professor C. David Weaver, where he discovered and studied small molecule modulators of ion channels implicated in neurological and cardiovascular disease. Krystian’s postdoctoral research in the laboratory of Professor Brett Kroncke involved determining the functional and clinical implications of genetic variations in an ion channel critical to normal heart rhythmicity.
He earned a B.S. in Materials Science and Engineering and a B.A. in Chemistry from the North Carolina State University. His undergraduate research was conducted in the laboratory of Professor Joseph Tracy, where he studied nanoscale materials and invented a method for large-scale batch synthesis of rod-shaped gold nanoparticles.
Krystian's scientific work has led to numerous publications, an awarded patent, and various awards, most notably from the Barry M. Goldwater Scholarship Foundation, the PhRMA Foundation, and the Canby Robinson Society. In addition to his academic pursuits, Krystian worked to inspire the next generation of physician-scientists with his leadership roles in outreach programs on behalf of the Vanderbilt University MSTP.